Rare diseases
Investigational molecules
Locations
4930 Directors Place Suite 500, 92121-3848, United States
Clinical research in relapsed and/or refractory acute myeloid leukemia and genetically defined AML subtypes, with emphasis on NPM1-mutated and KMT2A-rearranged disease.
Interest extends to menin inhibition and combination approaches in both newly diagnosed and previously treated myeloid malignancies.
Kura Oncology Inc. runs clinical trials in conditions such as Acute myeloid leukaemia, Acute myeloid leukaemia recurrent, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
